|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4035 | |
| A61P 1/16 | |||
| A61K 9/20 |
| (11) | Patento numeris | 3157520 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15739070.9 |
| Europos patento paraiškos padavimo data | 2015-06-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/036898 |
| Data | 2015-06-22 |
| (87) | Numeris | WO 2015/200177 |
| Data | 2015-12-30 |
| (30) | Numeris | Data | Šalis |
| 201462016013 P | 2014-06-23 | US |
| (72) |
HOUGH, Douglas, US
STEVENS, Randall, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | APREMILAST FOR THE TREATMENT OF A LIVER DISEASE OR A LIVER FUNCTION ABNORMALITY |
| APREMILAST FOR THE TREATMENT OF A LIVER DISEASE OR A LIVER FUNCTION ABNORMALITY |